Abingdon Health (LON:ABDX) Hits New 1-Year Low – Time to Sell?

Abingdon Health Plc (LON:ABDX)’s share price hit a new 52-week low on Friday . The stock traded as low as GBX 6 ($0.08) and last traded at GBX 6.25 ($0.08), with a volume of 121997 shares traded. The stock had previously closed at GBX 6.50 ($0.08).

Abingdon Health Stock Down 3.8 %

The stock has a market capitalization of £12.10 million, a price-to-earnings ratio of -15.20 and a beta of 0.13. The business has a 50-day moving average of GBX 7.18 and a 200-day moving average of GBX 7.78. The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95.

Abingdon Health (LON:ABDX) last announced its earnings results on Monday, March 24th. The company reported GBX (0.53) (($0.01)) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative return on equity of 62.56%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.